Gene · 4055
Papers3,299
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,299
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Effect of Lower Limb Revascularization on Flow, Perfusion, and Systemic Endothelial Function: A Systematic Review. | Angiology | 2021 | 33143447 | PubTator, text mining | PubMed |
| The Dual Role of High Endothelial Venules in Cancer Progression versus Immunity. | Trends Cancer | 2021 | 33132107 | PubTator, text mining | PubMed |
| Preventing the development of severe COVID-19 by modifying immunothrombosis. | Life Sci | 2021 | 33096114 | PubTator, text mining | PubMed |
| Understanding the role of neutrophils in acute respiratory distress syndrome. | Biomed J | 2021 | 33087299 | PubTator, text mining | PubMed |
| NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development. | Transl Oncol | 2021 | 33074124 | PubTator, text mining | PubMed |
| Effects of hydroxyurea on cytotoxicity, inflammation and oxidative stress markers in neutrophils of patients with sickle cell anemia: dose-effect relationship. | Hematol Transfus Cell Ther | 2021 | 33051133 | PubTator, text mining | PubMed |
| Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? | Pharmacol Ther | 2021 | 33031856 | PubTator, text mining | PubMed |
| A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders. | Kidney Int | 2021 | 32717193 | PubTator, text mining | PubMed |
| Biological mechanisms of ectopic lymphoid structure formation and their pathophysiological significance. | Int Rev Immunol | 2021 | 32631119 | PubTator, text mining | PubMed |
| Genetics and epigenetics in primary Sjögren's syndrome. | Rheumatology (Oxford) | 2021 | 30770922 | PubTator, text mining | PubMed |
| Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer. | Explor Target Antitumor Ther | 2020 | 36046484 | PubTator, text mining | PubMed |
| The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer. | Front Oncol | 2020 | 33680942 | PubTator, text mining | PubMed |
| Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily. | Front Cell Dev Biol | 2020 | 33644033 | PubTator, text mining | PubMed |
| B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps. | Front Immunol | 2020 | 33552090 | PubTator, text mining | PubMed |
| A Putative Serine Protease is Required to Initiate the RIPK3-MLKL-Mediated Necroptotic Death Pathway in Neutrophils. | Front Pharmacol | 2020 | 33551816 | PubTator, text mining | PubMed |
| Decrease of Clone Diversity in IgM Repertoires of HBV Chronically Infected Individuals With High Level of Viral Replication. | Front Microbiol | 2020 | 33519772 | PubTator, text mining | PubMed |
| Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma. | Oncoimmunology | 2020 | 33457102 | PubTator, text mining | PubMed |
| The Role of cis- and trans-Acting RNA Regulatory Elements in Leukemia. | Cancers (Basel) | 2020 | 33419342 | PubTator, text mining | PubMed |
| Effect of Bitis gabonica and Dendroaspis angusticeps snake venoms on apoptosis-related genes in human thymic epithelial cells. | J Venom Anim Toxins Incl Trop Dis | 2020 | 33402885 | PubTator, text mining | PubMed |
| A Disintegrin and Metalloproteinase-Control Elements in Infectious Diseases. | Front Cardiovasc Med | 2020 | 33392273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4055/papers?page=51